Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Population-based cohort, case-control, cross-sectional, or genome-wide association studies reporting associations between the PPARG Pro12</span>Ala gene variant (rs1801282) and type 2 diabetes were included. 20179158 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Three-site haplotype analysis in the PPARG locus using the 2 marginally associated SNPs (P/rs11715073 and P/rs3892175) in combination with Pro12 Ala (P/rs1801282) revealed a strong association of 1 "risk" (CGC) (P = .003, permutation P = .015) and 1 "protective" (CAC) (P = .001, permutation P = .005) haplotype associated with T2D. 19846176 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala polymorphism has been associated with a higher BMI and a lower risk of type 2 diabetes in adulthood. 19846795 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although our data indicate that the PPARG2 gene variants, independently, have no association with type 2 diabetes mellitus, the 2-loci genotype analysis involving -1279G/A and Pro12Ala variants and the 3-loci haplotype analysis have shown a significant association with type 2 diabetes mellitus in this South Indian population. 19846173 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor (PPAR-gamma) gene is inversely associated with body mass index (BMI), changes in BMI and the risk to develop type 2 diabetes mellitus. 19808901 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE To explore the way that population description is used to replicate and/or extend previously reported genetic observations, we examined articles describing the association of the peroxisome proliferator-activated receptor-gamma-gamma Pro12Ala polymorphism with type 2 diabetes mellitus and related phenotypes, published between 1997 and 2005. 20157827 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The PPAR-gamma Pro12Ala gene polymorphism is associated with the response to pioglitazone in Chinese patients with type 2 diabetes mellitus. 20045142 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism in the gene encoding PPARγ (PPARγ2 gene) influences the risk for type 2 diabetes. 21206011 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE To determine whether the Pro12Ala polymorphism, alone or in combination with smoking, contributes to the development of diabetic nephropathy, a case-control study was performed in 760 Chinese patients with type 2 diabetes. 19837787 2010
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma (PPARgamma) has been associated with decreased obesity, insulin resistance, type 2 diabetes and other age-associated diseases such as cognitive impairment, hypertension, cancer, osteoarthritis. 19766907 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Together, these results showed that PPARG Pro12Ala and PPARGC1A Gly482Ser variants are associated, alone and in interaction, with insulin and glucose homeostasis and suggest that gene-gene interactions should be taken into account in candidate gene studies of T2DM to identify subjects with markedly different risks of developing the disease. 19536736 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Although no interactions between the four variants on the risk of type 2 diabetes were detected, the multiplicative interaction between PPARG Pro12Ala and HNF4A rs2144908 was found to be associated with 2-hour postprandial insulin (P = 0.004 under an additive model for rs2144908; and P = 0.001 under a dominant model for rs2144908) after adjusting for age, sex and BMI, assuming a dominant model for PPARG Pro12Ala. 20079163 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism (rs1801282), a nonsynonymous substitution of peroxisome proliferator-activated receptor-gamma (PPARG), has been robustly associated with type 2 diabetes. 19745552 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE No effect of the Pro12Ala polymorphism on the rates of whole-body, skeletal muscle, or subcutaneous adipose tissue GU was observed in T2DM subjects. 19303976 2009
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The alanine variant of the Pro12Ala polymorphism of PPARgamma might be associated with decreased risk of DR in T2DM. 18077048 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma 2 gene is suggested to associate with diabetic nephropathy and cardiovascular disease in type 2 diabetes. 18467141 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Amongst non-obese individuals, we observed significant T2D associations with HNF1A I27L [odds ratio (OR) = 1.14, P = 0.04], GCK -30G>A (OR = 1.23, P = 0.01), SLC30A8 R325W (OR = 0.87, P = 0.04), and TCF7L2 rs7903146 (OR = 1.89, P = 4.5 x 10-23), and non-significant associations with PPARG Pro12Ala (OR = 0.85, P = 0.14), ADIPOQ -11,377C>G (OR = 1.00, P = 0.97) and ENPP1 K121Q (OR = 0.99, P = 0.94). 18498634 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The rs17036314, rs1801282 (Pro12Ala), and rs1152003 were associated with the risk of T2D in the DPS. 18091023 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The P12A variant in the PPARG gene and the E23K polymorphism in KCNJ11 are both known to influence individual predisposition to type 2 diabetes. 17994213 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Conflicting evidence exists as to whether the Pro12Ala single nucleotide polymorphism of the type 2 diabetes susceptibility gene peroxisome proliferator-activated receptor gamma (PPARG) also confers risk for type 1 diabetes (T1D). 18466209 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE The Pro12Ala variant in the PPAR-gamma2 (PPARG) gene was genotyped in 571 non-diabetic relatives of subjects with type II diabetes. 17700648 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Four of the nine SNPs revealed a significant association with T2D; PPARG2 (Pro12Ala) [odds ratio (OR) 0.12; 95% confidence interval (CI) (0.03-0.52); p = 0.005], IGF2BP2 [OR 1.37; 95% CI (1.04-1.82); p = 0.027], TCF7L2 [OR 1.64; 95% CI (1.20-2.24); p = 0.001] and FTO [OR 1.46; 95% CI (1.11-1.93); p = 0.007] after adjusting for age, sex and BMI. 18598350 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE To assess for any association of ENPP1-K121Q and PPARgamma-Pro12Ala polymorphisms with T</span>2D risk, we analysed the genotypic and allelic distributions of each variant in the studied cohort. 18657335 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE Neither PPARG2 Pro12Ala nor any of the nine HNF4A SNPs were independently associated with type 2 diabetes-related quantitative traits. 18162503 2008
Diabetes Mellitus, Non-Insulin-Dependent
0.100 GeneticVariation BEFREE We did not find any significant association between three SNPs in the PGC-1alpha gene and T2DM in Hispanics or NHW; however, using FBAT, we found the common Thr612Thr allele of the PGC-1alpha gene to be associated with T2DM among Hispanic subjects carrying the rare Pro12Ala allele of the PPAR-gamma gene (p=.003). 17479445 2007